Biomedical subjects
Publications and source records attributed to Jan Reedijk.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The 22-membered macrocycle, containing four endocyclic pyrazole groups and two exocyclic pyridine groups, viz. (9,22-di(pyridin-2-ylmethyl)-1,4,9,14,17,22,27,28,29,30-decaaza-5,13,18,26-tetramethyl)pentacyclo[24.2.1.1(4,7).1(11,14).1(17,20)]triacontane-5,7(28),11(29),12,18,20(30),24(27),25-octaene (MePy22Pz), has been synthesized in an eleven-step procedure. Two dinuclear copper(II) compounds, viz. [Cu(2)(MePy22Pz)(NO(3))(4)](MeOH)(2) (A) and [Cu(2)(MePy22Pz)(CF(3)SO(3))(2)(H(2)O)(2)](CF(3)SO(3))(2)(MeOH)(2) (B), were prepared with this macrocycle. In both compounds the copper(II) ions are in a square pyramidal N(3)O(2) environment involving a pyrazole nitrogen, a pyridine nitrogen, and a tertiairy amine nitrogen and two oxygen atoms, which stem from two different nitrate anions in compound A and from a triflate anion and a water molecule in compound B. Two of the four pyrazole groups of the macrocycle do not participate in the coordination. The pendent pyridine groups protrude on opposite sides of the macrocycle. Consequently, the copper ions are on different sides of the macrocyclic ring and quite far apart with Cu-Cu distances of 8.668(4) Å in A and 6.814(1) Å in B.
Explore the source record for details and available documents.
The X-ray structures and spectroscopic and magnetic properties of [tetrakis(&mgr;-1-phenylcyclopropane-1-carboxylato-O,O')bis(ethanol-O)dicopper(II)], 1, and catena-poly[[bis(&mgr;-diphenylacetato-O:O')dicopper](&mgr;(3)-diphenylacetato-1-O:2-O':1'-O')(&mgr;(3)-diphenylacetato-1-O:2-O':2'-O')], 2, two extended-chain copper(II) carboxylates with dinuclear paddle-wheel subunits, are reported. 1 crystallizes in the triclinic space group P&onemacr;, with a = 6.8873(3) Å, b = 11.7367(6) Å, c = 13.7899(7) Å, alpha = 107.076(4) degrees, beta = 93.545(4) degrees, gamma = 103.967(4) degrees, Z = 1. The Cu.Cu distance is 2.6009(4) Å, and the Cu.carboxylate O distances are in the range 1.937(2)-1.962(2) Å. The ethanol at the apex forms an unsymmetrical bifurcated H bond to two carboxylate oxygens of another dinuclear unit with O.O distances 2.980(3) and 3.108(3) Å, thereby extending the structure along the a-axis. The magnetic structure consists of isolated antiferromagnetically coupled dinuclear copper units, with a -2J value of 242 cm(-)(1), in concurrence with the EPR parameters, viz., g(x)() = 2.03(1), g(y)() = 2.07(1), g(z)() = 2.35(1), A( parallel) = 0.064(2) cm(-)(1), D = 0.316(15) cm(-)(1), E = 0.005(1) cm(-)(1). The -2J value is the smallest value measured for dinuclear copper carboxylates with oxygen-donor ligands at the axial position and no electron-withdrawing carboxylate R groups. 2 crystallizes in the monoclinic space group P2(1)/c, with a = 15.953(2) Å, b = 5.385(6) Å, c = 28.322(10) Å, beta = 120.22(3) degrees, Z = 2. The compound contains tetrakis(diphenylacetato)dicopper(II) units, forming a polymeric structure along the b-axis by axial coordination of a carboxylate oxygen to copper of a subsequent dinuclear unit, at 2.323(11) Å. The intradimer Cu.Cu distance is 2.594(4) Å; the interdimer Cu.Cu distance is 3.425(5) Å. The -2J value of 321 cm(-)(1) was interpreted as originated from isolated antiferromagnetically coupled dinuclear copper units. The EPR parameters are g(x)() = 2.07(1), g(y)() = 2.02(1), g(z)() = 2.33(1), D = 0.347(10) cm(-)(1), E = 0.0034(5) cm(-)(1). The dinuclear subunits are likely candidates for the catalytically active Cu species in copper(II)-catalyzed oxidation of carboxylic acids.
The synthesis, characterization, and electrochemical, photophysical, and photochemical properties of the compounds [Ru(bpy)(2)(L)](2+) (Ru), [Os(bpy)(2)(L)](2+) (Os), [(L)Os(bpy)(2)Cl](+) (OsCl), [Ru(bpy)(2)(L)Ru(bpy)(2)Cl](3+) (RuRuCl), [Os(bpy)(2)(L)Os(bpy)(2)Cl](3+) (OsOsCl), [Ru(bpy)(2)(L)Os(bpy)(2)Cl](3+) (RuOsCl), and [Os(bpy)(2)(L)Ru(bpy)(2)Cl](3+) (OsRuCl) are reported (bpy = 2,2'-bipyridine, L = 1-methyl-3-(pyrazin-2-yl)-1,2,4-triazole). The Os(bpy)(2) and the Ru(bpy)(2) moieties are coordinated to the pyrazyltriazole ligand in two different ways, i.e. in a bidentate fashion via the triazole ring and N1 of the pyrazine ring and in a monodentate fashion only via N4 of the pyrazine ring. In the homonuclear dimers the monodentate bound metal has an oxidation potential that is approximately 400 mV lower than that of the bidentate bound metal. Spectroelectrochemical investigations suggest the presence of a weak interaction between the metal centers in the dinuclear species. The emission properties of the compounds are indicative of efficient energy transfer in the excited state, leading to emission from only one metal unit. In acetone both RuRuCl and the OsRuCl show photodissociation of the monodentate ruthenium moiety; however, RuOsCl and OsOsCl were found to be photostable.
Explore the source record for details and available documents.
Two new iron(II) compounds with the formula [Fe(3)(iptrz)(6)(H(2)O)(6)]X(6).xH(2)O (with iptrz = 4-isopropyl-1,2,4-triazole and X = p-toluenesulfonate (Tos) or trifluoromethanesulfonate (Trifl)) were synthesized. The crystal structure of [Fe(3)(iptrz)(6)(H(2)O)(6)](Tos)(6).2H(2)O (I) has been solved at room temperature. Crystals of I are triclinic, space group P&onemacr; with a = 12.8820(11) Å, b = 15.580(2) Å, c = 24.445(4) Å, alpha = 79.270(12) degrees, beta = 86.688(11) degrees, gamma = 83.007(8) degrees, Z = 2. The structure of I consists of linear trinuclear cations with a +6 charge and noncoordinated anions and lattice water molecules. The central iron ion is located on an inversion center and is coordinated by 6 nitrogen atoms of 6 iptrz molecules bridging via the nitrogen atoms in the 1,2-positions. Each external iron atom completes its coordination sphere with three coordinated water molecules. The temperature dependent magnetic measurements of compound I and [Fe(3)(iptrz)(6)(H(2)O)(6)](Trifl)(6) (II) show that both compounds exhibit a gradual spin conversion of the central iron ion centered at T(1/2) = 242 K for I and 187 K for II. Temperature dependent Mössbauer spectroscopy measurements on I show the behavior expected for a compound of this nature. The measurements on II indicate a strong influence of the spin conversion of the central iron ion on both external iron ions. The nature of this phenomenon is proposed to be connected to a very rigid lattice structure (ionic, H-bonding) connecting the trinuclear units.
A new dinucleating ligand, 1,5-bis(1-pyrazolyl)-3-[bis(2-imidazolyl)methyl] azapentane (Hbpzbiap), containing pyrazoles and imidazoles has been designed and synthesized. The synthesis and characterization of the copper complexes with the ligand Hbpzbiap and its dehydronated form are described. This study is aimed at modeling the active site of copper-zinc superoxide dismutase (SOD). Single crystals of the imidazolato-bridged complex [Cu(2)(bpzbiap)Cl(3)] (1) and non-imidazolato-bridged complex [Cu(2)(Hbpzbiap)Cl(4)] (2) were obtained and their structures determined by X-ray diffraction. Both structures show two copper centers in two different coordination environments: a distorted square pyramid and a distorted tetrahedron. The Cu-nitrogen bond lengths range from 1.919(4) to 2.039(3) Å and are as expected. The copper-copper distances from 5.566(1) to 6.104(1) Å being only slightly shorter than that found in bovine erythrocyte SOD. Temperature-dependent magnetic susceptibility study of 1 shows antiferromagnetic behavior with -2J = 96 cm(-)(1). From pH-dependent electron paramagnetic resonance and electronic spectra, [Cu(2)(bpzbiap)Cl(3)] has been demonstrated to be stable over a quite wide pH range including the physiological pH values. A low concentration of this complex (1) catalyzes the dismutation of superoxide at biological pH. Voltammetric studies indicate a quasi-reversible redox behavior in aqueous solution at pH 7. These results clearly indicate that complex 1 is a good model for superoxide dismutase.
The synthesis and characterization of three dinuclear copper(II) complexes and one mixed-valence tetranuclear cluster with the asymmetric imidazole-containing ligand bis(1,1'-imidazole-2-yl)(4-imidazole-4(5)-yl)-2-azabutane (biib) are described. X-ray crystallographic parameters for the copper complexes are as follows. [Cu(2)(biib)(2)(BF(4))(2)](BF(4))(2)(H(2)O)(4): triclinic, space group P&onemacr;, a = 10.178(1) Å, b = 9.4881(9) Å, c = 11.037(1) Å, alpha = 95.130(10) degrees, beta = 112.20(1) degrees, gamma = 92.142(9) degrees, and Z = 1. [Cu(2)(biib)(2)(NO(3))(2)](NO(3))(2)(H(2)O)(4): monoclinic, space group &Pmacr;2(1)/n, a = 9.207(6) Å, b = 17.0516(6) Å, c = 12.6107(7) Å, beta = 109.82(1) degrees, and Z = 2. [Cu(2)(biib)(2)(CuBr(3))(2)]: monoclinic, space group P2(1)/c, a = 11.583(2) Å, b = 11.864(2) Å, c = 16.070(2) Å, beta = 112.459(12) degrees, and Z = 2. The two Cu(II) ions in all four complexes are coordinated in a square-pyramidal geometry by three imidazole nitrogens and one amine nitrogen donor in the equatorial plane, and each copper ion is weakly coordinated at the axial position by respectively a tetrafluoroborate, a perchlorate, a nitrate, or a tribromocuprate(I) anion. By comparison of the structural data of the four complexes a relationship has been established between the donor strength of the anion and some structural features, like the Cu(II)-Cu(II) distance, of the dinuclear Cu(II)-Cu(II) unit in the four complexes. Single-crystal EPR spectra of [Cu(2)(biib)(2)(BF(4))(2)](BF(4))(2)(H(2)O)(4) were recorded at room temperature at X-band frequencies. The triplet spectra have been fit with nonparallel g and D tensors, whose principle values are as follows: g(xx)() = 2.022(8), g(yy)() = 2.060(7), g(zz)() = 2.211(8), D(x)()(')(x)()(') = -0.0182(9) cm(-)(1), D(y)()(')(y)()(') = -0.081(6) cm(-)(1), D(z)()(')(z)()(') = 0.0264(7) cm(-)(1). The compounds were further characterized and studied by ligand field and by frozen-solution and polycrystalline powder EPR spectroscopy. EPR spectra recorded at 77 K of frozen solutions of the perchlorate complex show that upon dilution in methanol the dinuclear complex reacts to form a mononuclear species.
The influence of the molecular crystalline arrangement upon the state of a Jahn-Teller-active center has been investigated in crystals of the complex Cu(mtz)(6)(BF(4))(2), where mtz = 1-methyltetrazole. Crystal structures at 293, 123, and 93 K were determined by X-ray diffraction for the copper complex and at 293 and 100 K also for the analogous zinc complex, Zn(mtz)(6)(BF(4))(2). The respective lattice parameters for the copper complex at 293, 123, and 93 K are as follows: a = 18.137(4), 17.597(4), 17.575(4) Å; b = 10.247(4), 10.131(4), 10.133(4); c = 18.446(5), 18.531(4), 18.535(4) Å; beta = 112.62(2), 113.55(2), 113.61(2) degrees. Those for the zinc complexes at 293 and 100 K, respectively, are as follows: a = 18.153(2), 17.663(2) Å; b = 10.289(1), 10.159(2) Å; c = 18.506(3), 18.578(3) Å; beta = 113.21(1), 114.15(2) degrees. The crystal system is monoclinic, space group P2(1)/n (Z = 4), for all crystals with two crystallographically inequivalent pairs of centrosymmetric molecules, M(mtz)(6)(BF(4))(2), in the unit cell. The two inequivalent Cu(mtz)(6)(2+) complexes, Cu(A) and Cu(B), both exhibit Jahn-Teller distortions, but in different ways, the Cu-N distances for the unit on site A being 2.015(4), 2.031(5), and 2.384(5) Å at 93 K, while those for the unit on site B are 2.053(5), 2.126(5), and 2.204(5) Å. However, the Jahn-Teller radii of the two complexes, as calculated from the metal-ligand distances and the U tensors of the two CuN(6) units, were both found to be 0.41(3) Å. EPR experiments at room temperature on polycrystalline samples of the pure copper compound and of the copper-doped zinc compound confirm the presence of two different Jahn-Teller centers; both complexes are rapidly pulsating, but the CuN(6) units on site A are confined predominantly to one potential well of the warped Mexican hat potential, whereas the CuN(6) units on site B have density in all three wells. At 78 K, however, the spectrum of the polycrystalline material is consistent with a single site having an axial g tensor with maximum anisotropy (g( parallel) = 2.300(5), g( perpendicular) = 2.068(5)). While the low-temperature X-ray results also indicate a structure in which the Cu(A) center is exclusively populated in one potential well, the U tensor and potential well population data for the Cu(B) centers indicate that at 93 K a nonpulsating averaged structure based on tetragonally elongated CuN(6) units is being observed. The more pronounced preference for the CuN(6) octahedron on site A to show elongation in one specific direction, in contrast to that on the B site, appears to be due to the differing impacts of the local-site strains at the two distinct centers of symmetry, and a simple model for evaluating a crystal "packing" strain from the bond length data for the isomorphous zinc complex is described.
The automated parallel solid-phase synthesis of a 36-member library of peptide-tethered platinum(II) complexes is described. The identity and quality of each product were confirmed by mass spectrometry and (1)H NMR. Subsequently, each compound was screened for in vitro anticancer activity by treating the A2780 (human ovarian carcinoma) cell line with two concentrations of the drugs (100 and 10 microM) in quadruplicate. The reduction of cell proliferation induced by the drugs at these concentrations was determined with the MTT colorimetric assay (MTT = 3-(4',5'-dimethylthiazol-2'-yl)-2,5-diphenyltetrazolium bromide) and compared to cisplatin. Even though no very active library members could be identified, five apparently most active (8[1], 8[4], 8[10], 8[13], and 8[24]) and two inactive complexes (8[33] and 8[34]) were purified using gel permeation chromatography and fully characterized by NMR spectroscopy ((1)H, (195)Pt) and MS. The IC(50) values of these complexes and cisplatin in A2780 cells were subsequently determined using the MTT assay in a conventional manner. All seven complexes have an IC(50) above 100 microM, confirming the results generated by the assay at 100 and 10 microM of the crude reaction products.
AP 5280 is a novel polymer-conjugated platinum anticancer agent currently in Phase I clinical trials. In order to guarantee the quality of AP 5280 drug substance for use in the manufacture of a drug product for intravenous human use, an array of tests was utilized for its quality control. Proton nuclear magnetic resonance (1H NMR) spectroscopy and infrared (IR) spectroscopy were employed for structural identification. The molecular weight (MW) and MW distribution, which play a large role in the distribution of AP 5280 in vivo, were determined by Size Exclusion Chromatography (SEC). Platinum binding assessment was performed using platinum nuclear magnetic resonance (195Pt NMR) spectroscopy. The free platinum content and release profile of small platinum species, measured using Flameless Atomic Absorption Spectroscopy (F-AAS), were determined as a measure of molecular integrity, a very important aspect of its assumed mechanism of action. The total platinum content of the copolymer was determined employing flame Atomic Absorption Spectroscopy (AAS). The combined results of the analyses performed on AP 5280 drug substance provided a meaningful picture of its structure, size, and integrity--an excellent basis for its quality control.